MPs debate access to Kadcyla and other breast cancer drugs
19 January 2017
Watch the debate and read the transcript
The House of Commons Library also produced a briefing paper which includes more information on the debate's topic.
The Motion debated and approved
"That this House notes the provisional decision not to provide the breast cancer drug Kadcyla for use in the NHS on 29 December 2016; and calls on the National Institute for Health and Care Excellence (NICE) and pharmaceutical company Roche to come together and re-assess this decision to ensure Kadcyla is kept available for patients, and consider how access to both innovative new breast cancer drugs and off-patent drugs used for breast cancer, such as bisphosphonates, can be improved."
Backbench Business Committee
The Backbench Business Committee meets weekly on Tuesdays to consider requests for debates from any backbench Members of Parliament on any subject.
The Committee then has to decide how to allocate the limited Parliamentary time it has at its disposal. The Committee's meetings are always conducted in public and can be watched on Parliament TV.
This debate was determined by the Backbench Business Committee following an application from Siobhain McDonagh who will lead the debate.
- About Parliament
- How the Backbench Business Committee works
- Follow updates from the Committee on Twitter